Clinical Trials Logo

Alexithymia clinical trials

View clinical trials related to Alexithymia.

Filter by:

NCT ID: NCT06341829 Not yet recruiting - Parkinson Disease Clinical Trials

Visuospatial and Affective Abilities in Parkinson Disease

Start date: April 17, 2024
Phase: N/A
Study type: Interventional

The aim of the study is to investigate whether prismatic adaptation (AP), a non-invasive neuromodulation technique, that involves the use of lenses that deviate the visual field, can modulate alexithyima and performance in visuospatial tasks in patients with Parkinson disease. Furthermore, brain activity during the prismatic adaptation and post-adaptation phases will be recorded using functional near-infrared spectroscopy (fNIRS) and high-density electroencephalography (HD-EEG).

NCT ID: NCT05832281 Recruiting - HIV Clinical Trials

Role of CBD in Improving Alexithymia

ACBD
Start date: November 28, 2023
Phase: Phase 2
Study type: Interventional

Given the treatments that are available today for HIV disease, people living with HIV (PLWH) can generally expect good medical outcomes. However, HIV is still a chronic disease and there are remaining barriers to achieving ideal health status and quality of life. One barrier may be a condition that is common among PLWH, called alexithymia, which can make it difficult for a person to name and describe the emotions that they are feeling. As a result, it is difficult to resolve negative emotional states, which can then lead to worse outcomes over time due to ongoing stress and related problems such as inflammation. In this study the investigators will try to find out whether taking cannabidiol (CBD) helps PLWH who have alexithymia to resolve those negative emotional states, which may then reduce inflammation in the body as a result. CBD may work by enhancing the body's own chemical messengers that can help to regulate emotions and encourage emotional benefits. The investigators will compare a group of people who take CBD for 4 weeks to those who take a placebo, which is a substance that will closely resemble the CBD but will not contain any active drug. Study participants and the researchers who are working directly with the participants will not be able to tell which is the CBD and which is the placebo. The investigators will evaluate participants before and after the 4-week study period. They will also collect samples, such as blood, so that we can measure inflammation. The investigators will compare the two groups to see if those who took CBD have lower alexithymia and lower inflammation compared to those who took the placebo. The potential benefit of this study is that CBD may be an effective treatment for alexithymia in PLWH, which may then improve both their emotional and physical health outcomes. This can help to address a remaining barrier to good medical outcomes for PLWH.

NCT ID: NCT05662137 Completed - Schizophrenia Clinical Trials

The Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia Patients

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

As a result of the positive and negative symptoms that occur in schizophrenia, patients with schizophrenia may experience negative emotions more frequently than individuals with other mental problems. Since these emotions can trigger psychotic symptoms, there is a need to develop effective emotion regulation strategies to be applied to patients with schizophrenia. Aim: In this study, it was aimed to examine the effect of emotion recognition and expression program on alexithymia and emotion expression in patients with schizophrenia.

NCT ID: NCT05623046 Recruiting - Concussion, Brain Clinical Trials

Building Emotional Self-Awareness Teletherapy (BEST)

BEST
Start date: February 23, 2023
Phase: N/A
Study type: Interventional

To examine the feasibility, acceptability, and preliminary efficacy of a remotely delivered intervention for civilians and service members with mild traumatic brain injury (mTBI) who have difficulty recognizing and regulating their emotions. Post-treatment outcomes of interest include emotional self-awareness and regulation, resiliency, and affective symptoms.

NCT ID: NCT05460806 Completed - Quality of Life Clinical Trials

The Effect of Aerobic Exercise in Alexithymic Individuals With Chronic Pain

Start date: July 12, 2022
Phase: N/A
Study type: Interventional

It was aimed to investigate the effect of aerobic exercise on pain, alexithymia level and quality of life in young alexithymic individuals with chronic pain. There is no study in the literature comparing the effectiveness of aerobic exercise on alexithymia and chronic pain. Since our study will be the first study to investigate the subject, we foresee that it is scientifically important and will shed light on future studies. In addition, it is planned to make national or international papers and publications after the study is completed.

NCT ID: NCT05344820 Recruiting - Cancer Clinical Trials

The Effect of the Art-based Mandala Intervention on the Quality of Life of Cancer Patients Receiving Chemotherapy

ARQULA
Start date: May 19, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of mandala application on fatigue, quality of life, rumination and alexithymia in cancer patients receiving chemotherapy.

NCT ID: NCT05342142 Recruiting - Depression Clinical Trials

Effects of 12-week Exercises on Alexithymia, Depression and Quality of Life in Geriatric Individuals

EXQUALITY
Start date: February 23, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effects of aerobic and resistance exercises on depression, alexithymia levels and quality of life of elderly individuals.

NCT ID: NCT05076201 Recruiting - Craving Clinical Trials

Process of Regulation in Addictions: Vulnerability Emotional Factors to Craving

Procrav
Start date: November 20, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to have a better understanding of the relationship between self-controle difficulties (and more specifically the inhibition deficit in impulsivity), emotional regulation disorders such as alexithymia and craving.This study will be the first in France to specify the interactions between self-regulkation processes dysfunctions and emotional dysfunctions in craving.

NCT ID: NCT04206930 Recruiting - Clinical trials for Alcohol Use Disorder

Impact of Art Therapy on Alexithymia in People With Alcohol Use Disorder

ALEXART
Start date: December 13, 2019
Phase: N/A
Study type: Interventional

Art therapy support combined with standard care for people with an alcohol use disorder coming to a day hospital for withdrawal could be beneficial compared to standard care alone because it would improve the alexithymia of these patients, helping them to better identify their feelings and / or emotions, and improve their self-confidence, their self-esteem self and their oral communication.

NCT ID: NCT03414463 Completed - Clinical trials for Traumatic Brain Injury

Training to Reconnect With Emotional Awareness Therapy

TREAT
Start date: May 8, 2018
Phase: N/A
Study type: Interventional

To decrease emotional self-awareness deficits and improve emotional self-regulation, particularly anxiety, anger, depression, and positive affect, through the treatment of alexithymia.